Investors & Media

Press Releases



All Releases
View Summary TG Therapeutics, Inc. to Host Conference Call on Second Quarter 2015 Financial Results and Business Update
Aug 5, 2015
PDF 14.7 KB Add to Briefcase
View Summary Updated Results From Phase 2 Clinical Trial of TG-1101 (Ublituximab) in Combination With Ibrutinib Confirms Robust Clinical Activity With a Favorable Safety Profile in Patients With Previously Treated, High-Risk Chronic Lymphocytic Leukemia (CLL)
Jun 18, 2015
PDF 23.2 KB Add to Briefcase
View Summary TG Therapeutics to Present Clinical Data on TG-1101 and TGR-1202 at the 20th Congress of the European Hematology Association and the 13th International Congress on Malignant Lymphoma
Jun 11, 2015
PDF 47.7 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the Jefferies 2015 Healthcare Conference
Jun 2, 2015
PDF 15.5 KB Add to Briefcase
View Summary TG Therapeutics Announces the Triple Combination of TG-1101, TGR-1202 and Ibrutinib is Safe and Highly Active in Patients With Advanced B-Cell Malignancies
Jun 1, 2015
PDF 66.5 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Presentations of Its Proprietary Combination of TG-1101 Plus TGR-1202 as Well as TGR-1202 as a Single Agent in Ongoing Phase I/Ib Dose Escalation Clinical Studies
May 31, 2015
PDF 111.9 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Recaps Schedule of Clinical Data Presentations at the 51st Annual Meeting of the American Society of Clinical Oncology
May 29, 2015
PDF 112.5 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Clinical Data Presentations at the Upcoming 51st Annual Meeting of the American Society of Clinical Oncology
May 13, 2015
PDF 19.1 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces First Quarter 2015 Financial Results and Business Update
May 4, 2015
PDF 62.1 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the Deutsche Bank 40th Annual Health Care Conference
May 1, 2015
PDF 13.9 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Host Conference Call on First Quarter 2015 Financial Results and Business Update
Apr 30, 2015
PDF 14.6 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Presents Pre-clinical Data on IRAK4 Compounds at the American Association for Cancer Research (AACR) Annual Meeting
Apr 20, 2015
PDF 17.0 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2014 Financial Results and Business Update
Mar 11, 2015
PDF 30.1 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Host Conference Call on Fourth Quarter and Year-End 2014 Financial Results and Business Update
Mar 10, 2015
PDF 108.4 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the 27th Annual ROTH Conference
Mar 6, 2015
PDF 106.0 KB Add to Briefcase
View Summary TG Therapeutics Enters Into a Global Collaboration With Checkpoint Therapeutics to Develop and Commercialize Novel Immuno-Oncology Targeted Antibodies
Mar 4, 2015
PDF 112.0 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the Cowen and Company 35th Annual Health Care Conference
Mar 2, 2015
PDF 106.1 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the 17th Annual BIO CEO & Investor Conference
Feb 4, 2015
PDF 106.0 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Provide an Update on Its Clinical Programs and Corporate Goals for 2015 at the 33rd Annual J.P. Morgan Healthcare Conference
Jan 15, 2015
PDF 109.8 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Jan 8, 2015
PDF 106.1 KB Add to Briefcase
Showing 81-100 of 183 Page: 1 2 3 4 5 6 7 8 9 10  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase